Search
for
Sort by
Research 91–120 of 1000+
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Editorial: Targeted immunological therapies in dermatology
- Recent Advances in Drug Development for Hair Loss
- UVB-induced depletion of donor-derived dendritic cells prevents allograft rejection of immune-privileged hair follicles in humanized mice
- Ostrich Antibody and Its Application to Skin Diseases, a Review and Case Report
- Drug-induced scarring and permanent alopecia
- Platelet Immune Interactions, Lifespan, and Senescence
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Targeting the Wnt pathways for therapies
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Cutaneous lupus erythematosus
- Thyroxine (T4) may promote re-epithelialisation and angiogenesis in wounded human skin ex vivo
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- 13. Wound Healing & Hair
- Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Emerging Therapies for Acne Vulgaris
- Unusual acute lupus hemophagocytic syndrome – a test of diagnostic criteria: a case report
- Premature hair graying: a multifaceted phenomenon
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Ottawa, Ontario, Canada, February 13–16, 2013